查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095465

單光子發射斷層掃描（SPECT）市場－2026-2032年全球市場預測

Single Photon Emission Computed Tomography Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

單光子發射電腦斷層掃描 (SPECT) 市場預計到 2032 年將成長至 30.2 億美元，複合年成長率為 4.09%。

主要市場統計數據
基準年 2025 22.8億美元
預計年份：2026年 23.7億美元
預測年份 2032 30.2億美元
複合年成長率 (%) 4.09%

單光子發射電腦斷層掃描（SPECT）仍然是核醫學影像的核心手段，尤其適用於評估生理功能，在循環系統、腫瘤學、神經病學、內分泌學以及感染疾病/發炎成像等領域應用廣泛。 SPECT 可檢測注射到患者體內的放射性示蹤劑所發射的伽馬射線，使臨床醫生能夠評估器官灌注、受體表達、骨骼代謝、心肌活力、腦血流以及其他僅靠解剖成像無法完全捕捉的分子水平過程。該技術的臨床效用已得到充分證實，這得益於放射性藥物的廣泛使用、標準化的成像方案以及醫院影像科、門診診斷中心和大學醫學機構的廣泛應用。

目前SPECT的發展趨勢受到早期疾病檢測、更精準的治療方案製定以及有效管理慢性疾病（例如冠狀動脈疾病、神經退化性疾病、甲狀腺疾病和骨轉移性疾病）需求的驅動。混合型SPECT/CT系統透過結合功能和解剖定位資訊提高了診斷可靠性，而檢測器技術、重建演算法、工作流程自動化和定量成像的進步則提高了影像品質、掃描效率和可重複性。監管機構對輻射安全、放射性藥物品質和實證合理使用的重視持續影響SPECT的應用和方案設計。隨著醫療保健系統優先考慮以價值為導向的醫療服務，SPECT的價值日益凸顯，不僅在於其診斷準確性，還在於其能夠指導治療決策、減少不必要的二次檢查以及支持疾病的長期監測。

SPECT領域的變革性變化

在技​​術現代化、臨床路徑演進以及精準醫療發展趨勢的推動下，SPECT生態系統正經歷變革性的轉變。在許多先進的影像環境中，混合SPECT/CT是首選配置，因為解剖抗蝕劑能夠改善病灶定位、衰減校正並提高觀察的可靠性。專用心臟SPECT系統、固體檢測器平台和最佳化的準直器設計能夠縮短採集時間並提高靈敏度，而當這些改進應用於檢驗的臨床方案時，則能夠提升患者的診療效率和舒適度。

人工智慧對SPECT的累積影響

人工智慧正在對整個SPECT價值鏈產生累積影響，涵蓋從患者準備和成像到重建、解讀、報告和品質保證的各個環節。人工智慧驅動的重建和去噪技術正被研究和應用，以提高影像品質、減少偽影，並在臨床適用的情況下實現低劑量或短時成像方案。機器學習模型可輔助進行衰減校正、運動校正、分割、病灶檢測和定量參數提取，有助於減少不同解讀者之間的差異，並在高通量成像環境中提高影像一致性。

SPECT的關鍵區域趨勢

在亞太地區，隨著醫療基礎設施的完善、癌症和心血管疾病篩檢計畫的日益成熟以及三級醫療機構對混合核醫學能力的投入，SPECT的臨床應用正在不斷擴展。中國、印度、日本、韓國和澳洲憑藉其先進的醫院網路、學術核醫學活動以及心臟病學、腫瘤學和神經病學領域對診斷成像日益成長的需求，在亞太地區的發展中發揮核心作用。日本和韓國正在大力推廣先進的診斷影像工作流程，而中國和印度則透過公共和私人醫療投資，擴大了大規模患者群體的SPECT服務覆蓋範圍。在東南亞，SPECT的發展與都市區醫院的現代化、專科醫生的培訓以及放射性藥物物流的改進密切相關。

SPECT 的關鍵組分析

在東南亞國協，由於都市區醫療體系的擴張以及對心臟、腫瘤、神經、骨骼和內分泌影像檢查需求的成長，SPECT正日益融入三級醫療服務體系。該地區取得進展的原因在於核醫專家資源分配不均、保險報銷體系差異以及島嶼和跨國地區對可靠放射性藥物供應鏈的需求。在海灣合作理事會（GCC）國家，SPECT的應用正透過先進的急診醫院基礎設施建設、國家醫療改革計劃以及對腫瘤和循環系統疾病服務的投資而不斷推進。先進的診斷技術、認證體係以及對專科護理的重視，正推動混合SPECT/CT系統在綜合診斷影像科室的整合。

主要國家SPECT的趨勢

美國擁有高度發展的SPECT（單光子發射電腦斷層掃描）環境，其在核心臟病學、先進的混合成像技術以及人工智慧驅動的工作流程最佳化方面已廣泛應用。加拿大強調標準化的臨床實踐、輻射安全以及各省醫療保健系統之間的公平可及性，而墨西哥正在擴大其在主要大都會圈醫院和私人診斷網路​​中的SPECT應用能力。巴西在主要都市區醫療中心的支持下，是拉丁美洲核醫學實踐的領導者，尤其是在腫瘤學、心臟病學和骨骼影像領域。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的創新，這些創新能夠在不增加操作複雜性的前提下，提高診斷可靠性、工作流程效率和病人安全性。影像服務提供者可以透過投資混合SPECT/CT設備、採用標準化方案、最佳化劑量實踐以及在臨床需要時擴展結構化報告來增強其SPECT專案。各機構應專注於員工在核子醫學技術、放射性藥物處理、輻射防護、定量成像和人工智慧驅動的工作流程監管方面的培訓，以確保各機構的品質一致性。

調查方法

本執行摘要採用系統化的二手研究途徑編寫，重點關注與單光子發射電腦斷層掃描（SPECT）相關的檢驗且基於證據的資訊來源。調查方法包括對臨床實踐指南、同行評審的核醫學文獻、監管指南、醫療技術評估、輻射安全標準、公共衛生數據、醫院影像工作流程文件以及專業學會建議的審查。特別關注檢驗的臨床應用、技術趨勢、監管考慮、當地醫療基礎設施以及影響SPECT和SPECT/CT應用的相關因素。

結論

單光子發射電腦斷層掃描（SPECT）在現代診斷成像中繼續發揮至關重要的作用，它提供的功能和分子資訊是對解剖成像方式的補充。混合型SPECT/CT系統、檢測器技術的進步、定量影像、放射性藥物的研發以及人工智慧驅動的工作流程改進進一步提升了SPECT的重要性。臨床需求主要來自心血管疾病、癌症、神經系統疾病、內分泌疾病、感染疾病和發炎以及肌肉骨骼疾病等仍棘手的疾病，所有這些疾病都能從針對特定患者診療路徑的標靶功能影像中獲益。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 單光子發射斷層掃描（SPECT）市場：依產品類型分類

  • 獨立式SPECT系統
  • 混合成像系統
  • 可攜式SPECT系統

第8章 單光子發射斷層掃描（SPECT）市場：依檢測器技術分類

  • 安格爾型閃爍攝影機技術
  • 固體檢測器技術
  • 混合檢測器技術

第9章：單光子發射斷層掃描（SPECT）市場：依組件類型分類

  • 硬體
    • 伽馬攝影機
    • 檢測器
    • 龍門架系統
    • 準直器
  • 軟體
    • 影像重建軟體
    • 影像分析軟體
    • 工作流程管理軟體
  • 服務
    • 安裝服務
    • 維護服務

第10章 單光子發射斷層掃描（SPECT）市場：依移動性分類

  • 固定式SPECT系統
  • 移動式SPECT系統

第11章 單光子發射斷層掃描（SPECT）市場：依病患類型分類

  • 成人
  • 兒童
  • 老年人

第12章 單光子發射斷層掃描（SPECT）市場：依應用分類

  • 循環系統
  • 神經病學
  • 腫瘤學

第13章 單光子發射斷層掃描（SPECT）市場：依最終用戶分類

  • 診斷中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 研究機構

第14章 單光子發射斷層掃描（SPECT）市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 單光子發射斷層掃描（SPECT）市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 單光子發射斷層掃描（SPECT）市場：依國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Agfa-Gevaert Group
  • Bracco Imaging SpA
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health Inc
  • Curium Pharma
  • Digirad Corporation
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc
  • Jubilant Radiopharmacies
  • Koninklijke Philips NV
  • Kromek Group PLC
  • Lantheus Medical Imaging Inc
  • Mediso Ltd
  • MILabs BV
  • Neusoft Corporation
  • NorthStar Medical Radioisotopes LLC
  • Samsung Medison Co. Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Spectrum Dynamics Medical Inc
  • United Imaging Healthcare Co. Ltd.
Product Code: MRR-02026C4CB810

The Single Photon Emission Computed Tomography Market is projected to grow by USD 3.02 billion at a CAGR of 4.09% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.28 billion
Estimated Year [2026] USD 2.37 billion
Forecast Year [2032] USD 3.02 billion
CAGR (%) 4.09%

Single Photon Emission Computed Tomography (SPECT) remains a core nuclear medicine imaging modality for functional assessment of physiology, particularly in cardiology, oncology, neurology, endocrinology, and infection/inflammation imaging. By detecting gamma photons emitted from radiotracers administered to patients, SPECT enables clinicians to evaluate organ perfusion, receptor expression, bone metabolism, myocardial viability, cerebral blood flow, and other molecular-level processes that are not fully captured by anatomical imaging alone. The modality's established clinical utility is supported by widely used radiopharmaceuticals, standardized acquisition protocols, and broad integration into hospital imaging departments, outpatient diagnostic centers, and academic medical institutions.

The current SPECT landscape is being shaped by demand for earlier disease detection, more precise therapy planning, and efficient management of chronic conditions such as coronary artery disease, neurodegenerative disorders, thyroid disease, and metastatic bone disease. Hybrid SPECT/CT systems have strengthened diagnostic confidence by combining functional information with anatomical localization, while advances in detector technology, reconstruction algorithms, workflow automation, and quantitative imaging are improving image quality, scan efficiency, and reproducibility. Regulatory emphasis on radiation safety, radiopharmaceutical quality, and evidence-based appropriate use continues to influence adoption and protocol design. As healthcare systems prioritize value-based care, SPECT is increasingly evaluated not only for diagnostic accuracy but also for its ability to guide treatment decisions, reduce unnecessary downstream procedures, and support longitudinal disease monitoring.

Transformative Shifts in the SPECT Landscape

The SPECT ecosystem is undergoing transformative shifts driven by technology modernization, evolving clinical pathways, and the broader movement toward precision medicine. Hybrid SPECT/CT has become a preferred configuration in many advanced imaging settings because anatomical co-registration improves lesion localization, attenuation correction, and interpretation confidence. Dedicated cardiac SPECT systems, solid-state detector platforms, and optimized collimator designs are supporting shorter acquisition times and improved sensitivity, which can enhance patient throughput and comfort when implemented within validated clinical protocols.

Radiopharmaceutical innovation is also redefining SPECT's role. Established tracers continue to anchor routine practice, while research and clinical translation are expanding applications in neuroendocrine tumors, parathyroid imaging, infection localization, dopamine transporter imaging, sentinel node mapping, and targeted radionuclide therapy planning. At the same time, healthcare providers are focusing on dose optimization through appropriate-use criteria, patient-specific protocols, and iterative reconstruction methods that support diagnostic-quality images with radiation-conscious workflows. Operationally, imaging departments are adopting digital scheduling, remote quality review, structured reporting, and integrated picture archiving to reduce variability and improve reporting efficiency. These shifts are positioning SPECT as a more connected, quantitative, and clinically actionable diagnostic tool rather than a standalone imaging procedure.

Cumulative Impact of Artificial Intelligence on SPECT

Artificial intelligence is creating a cumulative impact across the SPECT value chain, from patient preparation and acquisition to reconstruction, interpretation, reporting, and quality assurance. AI-enabled reconstruction and denoising techniques are being studied and implemented to improve image quality, reduce artifacts, and support lower-dose or shorter-duration imaging protocols where clinically appropriate. Machine learning models can assist in attenuation correction, motion correction, segmentation, lesion detection, and quantitative parameter extraction, helping reduce reader variability and improve consistency in high-volume imaging environments.

In cardiac SPECT, AI is increasingly relevant for automated perfusion assessment, ischemia evaluation, ventricular function analysis, and risk stratification when validated against clinical outcomes and expert interpretation. In neurology and oncology, AI-based pattern recognition may support more reproducible assessments of tracer distribution, disease progression, and treatment response. The most important near-term impact is likely to come from workflow augmentation rather than autonomous diagnosis: automated protocol checks, image quality alerts, standardized measurements, and structured reporting can help nuclear medicine teams operate more efficiently while maintaining physician oversight. However, responsible deployment requires transparent validation, data governance, cybersecurity controls, bias monitoring, regulatory compliance, and integration with existing clinical systems. Institutions adopting AI in SPECT must ensure that algorithms are trained and evaluated on representative datasets and that performance is continuously monitored in real-world practice.

Key Regional Insights for SPECT

Asia-Pacific is witnessing rising clinical utilization of SPECT as healthcare infrastructure expands, cancer and cardiovascular disease screening programs mature, and tertiary hospitals invest in hybrid nuclear medicine capabilities. China, India, Japan, South Korea, and Australia are central to regional development due to their advanced hospital networks, academic nuclear medicine activity, and growing demand for cardiac, oncology, and neurological imaging. Japan and South Korea demonstrate strong adoption of advanced imaging workflows, while China and India are expanding access across large patient populations through public and private healthcare investments. In Southeast Asia, SPECT growth is closely tied to urban hospital modernization, specialist training, and improving radiopharmaceutical logistics.

North America remains one of the most mature SPECT environments, supported by established nuclear cardiology practices, broad reimbursement structures, robust regulatory oversight, and strong use of hybrid imaging in hospitals and outpatient centers. The United States is particularly important for protocol standardization, cardiac SPECT utilization, AI-enabled workflow adoption, and clinical research, while Canada emphasizes quality assurance, radiation safety, and access across provincial healthcare systems. Latin America is advancing through expanded diagnostic imaging capacity in Brazil, Mexico, and other major economies, although access can vary substantially between urban centers and underserved regions. Europe benefits from structured nuclear medicine guidelines, strong academic collaboration, and widespread use of SPECT/CT in oncology, endocrinology, musculoskeletal imaging, neurology, and cardiology, with Germany, France, Italy, Spain, and the United Kingdom supporting diversified clinical application.

The Middle East is strengthening SPECT capabilities through investment in specialty hospitals, cancer centers, and cardiovascular care programs, especially in countries with advanced tertiary-care infrastructure. Adoption is supported by efforts to reduce outbound medical travel and improve local diagnostic capabilities. Africa presents a more heterogeneous landscape, with SPECT services concentrated in larger urban hospitals and academic centers. Key priorities across the continent include workforce development, radiopharmaceutical availability, equipment maintenance, radiation safety governance, and equitable access to diagnostic imaging.

Key Group Insights for SPECT

ASEAN countries are increasingly integrating SPECT into tertiary-care pathways as urban healthcare systems expand and demand rises for cardiac, oncology, neurology, bone, and endocrine imaging. The region's progress is shaped by uneven access to nuclear medicine specialists, differences in reimbursement, and the need for reliable radiopharmaceutical supply chains across island and cross-border geographies. GCC countries are advancing SPECT adoption through high-acuity hospital infrastructure, national health transformation programs, and investment in oncology and cardiovascular services. Their emphasis on advanced diagnostics, accreditation, and specialist care supports the integration of hybrid SPECT/CT systems within comprehensive imaging departments.

The European Union provides a highly structured environment for SPECT through harmonized radiation protection principles, clinical practice guidelines, cross-border research networks, and strong emphasis on quality assurance. EU healthcare systems are increasingly focused on appropriate utilization, dose optimization, and evidence-based imaging pathways. BRICS countries show diverse but strategically significant SPECT development: China and India are expanding capacity to serve large populations; Brazil and Russia maintain important nuclear medicine capabilities in major cities; and South Africa plays a central role in African nuclear medicine expertise and training. Within the G7, SPECT utilization is supported by advanced clinical guidelines, established reimbursement models, high levels of imaging infrastructure, and significant academic research activity. NATO member countries, many of which overlap with advanced European and North American health systems, benefit from mature hospital networks, standardized quality systems, and strong emphasis on healthcare resilience, imaging interoperability, and regulated use of radioactive materials.

Key Country Insights for SPECT

The United States represents a highly developed SPECT environment with extensive nuclear cardiology usage, advanced hybrid imaging capabilities, and growing interest in AI-supported workflow optimization. Canada emphasizes standardized clinical practice, radiation safety, and equitable access across provincial systems, while Mexico is expanding SPECT capacity in major metropolitan hospitals and private diagnostic networks. Brazil is a leading Latin American contributor to nuclear medicine practice, particularly in oncology, cardiology, and bone imaging, supported by major urban healthcare centers.

In Europe, the United Kingdom maintains strong nuclear medicine services across public and specialist hospital networks, with emphasis on clinical governance and appropriate-use pathways. Germany is notable for advanced imaging infrastructure, strong academic nuclear medicine programs, and broad SPECT/CT application. France supports structured nuclear medicine practice through specialist centers and national healthcare systems, while Russia has established capabilities in major hospitals and research institutions. Italy and Spain maintain active SPECT utilization in cardiology, oncology, endocrine, neurology, and musculoskeletal imaging, with modernization efforts focused on hybrid systems and workflow efficiency.

China is expanding nuclear medicine capacity through hospital infrastructure growth, specialist training, and rising demand for oncology and cardiovascular diagnostics. India is increasing access to SPECT in metropolitan centers and large hospital networks, driven by growing chronic disease burden and expanding private healthcare investment. Japan demonstrates mature nuclear medicine practice with high standards for imaging quality, aging-population-driven demand, and advanced clinical protocols. Australia supports SPECT through well-regulated nuclear medicine services, strong quality assurance, and access in major healthcare hubs, while South Korea combines advanced medical technology adoption with strong hospital-based imaging capabilities and active clinical research.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated innovation that improves diagnostic confidence, workflow efficiency, and patient safety without increasing operational complexity. Imaging providers can strengthen SPECT programs by investing in hybrid SPECT/CT capabilities where clinically justified, adopting standardized protocols, implementing dose optimization practices, and expanding structured reporting. Institutions should focus on staff training in nuclear medicine technology, radiopharmacy handling, radiation protection, quantitative imaging, and AI-assisted workflow oversight to ensure consistent quality across sites.

Technology developers should design SPECT systems and software that integrate smoothly with hospital information systems, radiology information systems, picture archiving platforms, and electronic health records. AI solutions should be developed with transparent validation, explainable outputs, cybersecurity safeguards, and post-deployment performance monitoring. Radiopharmaceutical stakeholders should focus on reliable production, cold-chain logistics, regulatory compliance, and tracer availability to support continuity of care. Healthcare executives should align SPECT investments with high-impact clinical pathways such as myocardial perfusion imaging, bone metastasis evaluation, parathyroid localization, infection imaging, neuroendocrine tumor assessment, and neurodegenerative disease evaluation. Collaboration among clinicians, physicists, technologists, regulators, and payers is essential to demonstrate clinical value, reduce variability, and expand appropriate access.

Research Methodology

This executive summary is developed through a structured secondary research approach focused on verified, evidence-based sources relevant to Single Photon Emission Computed Tomography. The methodology includes review of clinical practice guidelines, peer-reviewed nuclear medicine literature, regulatory guidance, health technology assessments, radiation safety standards, public health data, hospital imaging workflow documentation, and professional society recommendations. Emphasis is placed on validated clinical applications, technology trends, regulatory considerations, regional healthcare infrastructure, and adoption factors influencing SPECT and SPECT/CT implementation.

The research approach prioritizes triangulation across multiple credible source categories to reduce bias and improve reliability. Clinical insights are assessed based on established diagnostic use cases, appropriate-use guidance, and evidence supporting patient management decisions. Technology insights are evaluated through documented advancements in detector design, reconstruction methods, hybrid imaging, quantification, and artificial intelligence applications. Regional, group, and country-level insights are interpreted through healthcare infrastructure maturity, nuclear medicine capacity, workforce availability, radiopharmaceutical logistics, regulatory frameworks, and disease-burden relevance. The analysis intentionally excludes market sizing, market share, and forecasting to maintain focus on qualitative, data-backed industry intelligence.

Conclusion

Single Photon Emission Computed Tomography continues to play a vital role in modern diagnostic imaging by delivering functional and molecular information that complements anatomical modalities. Its relevance is being reinforced by hybrid SPECT/CT systems, improved detector technologies, quantitative imaging, radiopharmaceutical development, and AI-enabled workflow enhancement. Clinical demand is supported by the persistent burden of cardiovascular disease, cancer, neurological disorders, endocrine conditions, infection and inflammation assessment, and musculoskeletal disease, all of which benefit from targeted functional imaging in selected patient pathways.

The future of SPECT will be defined by its ability to deliver reproducible, efficient, and clinically actionable insights while meeting expectations for radiation safety, cost-effective care, and integrated digital workflows. Regions with mature nuclear medicine infrastructure are moving toward advanced quantification, automation, and evidence-based utilization, while emerging healthcare systems are focused on access, training, and radiopharmaceutical reliability. Organizations that combine technology modernization with rigorous quality management, responsible AI adoption, and patient-centered imaging protocols will be best positioned to strengthen the role of SPECT in precision diagnostics and longitudinal care management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Single Photon Emission Computed Tomography Market, by Product Type

  • 7.1. Introduction
  • 7.2. Standalone SPECT Systems
  • 7.3. Hybrid Imaging Systems
  • 7.4. Portable SPECT Systems

8. Single Photon Emission Computed Tomography Market, by Detector Technology

  • 8.1. Introduction
  • 8.2. Anger Scintillation Camera Technology
  • 8.3. Solid State Detector Technology
  • 8.4. Hybrid Detector Technology

9. Single Photon Emission Computed Tomography Market, by Component Type

  • 9.1. Introduction
  • 9.2. Hardware
    • 9.2.1. Gamma cameras
    • 9.2.2. Detectors
    • 9.2.3. Gantry systems
    • 9.2.4. Collimators
  • 9.3. Software
    • 9.3.1. Image Reconstruction Software
    • 9.3.2. Image Analysis Software
    • 9.3.3. Workflow Management Software
  • 9.4. Services
    • 9.4.1. Installation services
    • 9.4.2. Maintenance services

10. Single Photon Emission Computed Tomography Market, by Mobility

  • 10.1. Introduction
  • 10.2. Fixed Spect Systems
  • 10.3. Mobile Spect Systems

11. Single Photon Emission Computed Tomography Market, by Patient Type

  • 11.1. Introduction
  • 11.2. Adult
  • 11.3. Pediatric
  • 11.4. Geriatric

12. Single Photon Emission Computed Tomography Market, by Application

  • 12.1. Introduction
  • 12.2. Cardiology
  • 12.3. Neurology
  • 12.4. Oncology

13. Single Photon Emission Computed Tomography Market, by End User

  • 13.1. Introduction
  • 13.2. Diagnostic Centers
  • 13.3. Hospitals
    • 13.3.1. Private Hospitals
    • 13.3.2. Public Hospitals
  • 13.4. Research Institutes

14. Single Photon Emission Computed Tomography Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Single Photon Emission Computed Tomography Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Single Photon Emission Computed Tomography Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2025
  • 17.2. FPNV Positioning Matrix, 2025
  • 17.3. Market Concentration Analysis, 2025
    • 17.3.1. Concentration Ratio (CR)
    • 17.3.2. Herfindahl Hirschman Index (HHI)
  • 17.4. Recent Developments & Impact Analysis, 2025
  • 17.5. Product Portfolio Analysis, 2025
  • 17.6. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Agfa-Gevaert Group
  • 18.2. Bracco Imaging S.p.A.
  • 18.3. Bruker Corporation
  • 18.4. Canon Medical Systems Corporation
  • 18.5. Cardinal Health Inc
  • 18.6. Curium Pharma
  • 18.7. Digirad Corporation
  • 18.8. Fujifilm Holdings Corporation
  • 18.9. GE HealthCare Technologies Inc
  • 18.10. Jubilant Radiopharmacies
  • 18.11. Koninklijke Philips N.V.
  • 18.12. Kromek Group PLC
  • 18.13. Lantheus Medical Imaging Inc
  • 18.14. Mediso Ltd
  • 18.15. MILabs B.V.
  • 18.16. Neusoft Corporation
  • 18.17. NorthStar Medical Radioisotopes LLC
  • 18.18. Samsung Medison Co. Ltd.
  • 18.19. Shimadzu Corporation
  • 18.20. Siemens Healthineers AG
  • 18.21. Spectrum Dynamics Medical Inc
  • 18.22. United Imaging Healthcare Co. Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 27. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL STANDALONE SPECT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL STANDALONE SPECT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL STANDALONE SPECT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HYBRID IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HYBRID IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HYBRID IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PORTABLE SPECT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PORTABLE SPECT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PORTABLE SPECT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANGER SCINTILLATION CAMERA TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANGER SCINTILLATION CAMERA TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANGER SCINTILLATION CAMERA TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SOLID STATE DETECTOR TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SOLID STATE DETECTOR TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SOLID STATE DETECTOR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HYBRID DETECTOR TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HYBRID DETECTOR TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HYBRID DETECTOR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GAMMA CAMERAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GAMMA CAMERAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GAMMA CAMERAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DETECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DETECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DETECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GANTRY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GANTRY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GANTRY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COLLIMATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COLLIMATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COLLIMATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IMAGE RECONSTRUCTION SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMAGE RECONSTRUCTION SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IMAGE RECONSTRUCTION SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL WORKFLOW MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WORKFLOW MANAGEMENT SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WORKFLOW MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INSTALLATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INSTALLATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INSTALLATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAINTENANCE SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MAINTENANCE SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAINTENANCE SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FIXED SPECT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FIXED SPECT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FIXED SPECT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MOBILE SPECT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MOBILE SPECT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MOBILE SPECT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 195. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 196. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GCC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 225. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 231. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 232. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. G7 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 237. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 238. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 242. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 244. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. NATO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 262. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 267. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 268. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 269. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 270. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 274. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 279. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 280. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 281. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 282. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 286. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 291. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 292. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 293. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 294. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED KINGDOM SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED KINGDOM SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED KINGDOM SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTOR TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED KINGDOM SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED KINGDOM SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED KINGDOM SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED KINGDOM SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED KINGDOM SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED KINGDOM SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 310. GERMANY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. GERMANY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. GERMANY SINGLE PHOTON EMISSION COMPUTED TO